Andreas Emmendoerffer, MD, PhD
Principal Regulatory Program Director
Roche Pharma Ltd
MD by training and graduation at Medical School Hannover
More than 20 years in Regulatory Affairs and Quality in the space of medical devices, combination products, ATMPs.
Started professional career at Fraunhofer Society (Immunobiology), moved to biotech industry and currently at Roche Pharma Ltd, Basel. Involved in international registration of several drug device combinations in the field of neurology, ophthalmology and rare diseases.
Active in several industry organisations like MPP, ISPE and EFPIA.
